Drug name,DrugBank ID,Mechanism of action,Experimental activity,Measurement, Value,Unit
Beclabuvir,[DB12225](https://www.drugbank.ca/drugs/DB12225),RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors,"Hepatitis C (HCV) remission/reduction, IN VITRO",IC-50,3.00E-09,M
Remdesivir  ,[DB14761](https://www.drugbank.ca/drugs/DB14761),RNA-Dependent RNA Polymerase Inhibitor  ,"Ebola virus disease remission/reduction, IN VITRO  ",IC-50  ,1.00E-08,M
Valopicitabine,[DB13920](https://www.drugbank.ca/drugs/DB13920),RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors,"Hepatitis C (HCV) remission/reduction, IN VITRO",IC-50,9.00E-08,M
Mericitabine,[DB12045](https://www.drugbank.ca/drugs/DB12045),RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors,"Hepatitis C (HCV) remission/reduction, IN VITRO",IC-50,1.30E-07,M
Lumicitabine,[DB14808](https://www.drugbank.ca/drugs/DB14808),RNA-Dependent RNA Polymerase (Respiratory Syncytial Virus) Inhibitors,"Infection, respiratory syncytial virus (RSV) remission/reduction, IN VITRO",IC-50,2.60E-07,M
Sofosbuvir,[DB08934](https://www.drugbank.ca/drugs/DB08934),RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors,"Infection, dengue virus remission/reduction, IN VITRO",IC-90,4.00E-07,M
Adafosbuvir,[DB14906](https://www.drugbank.ca/drugs/DB14906),RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors,"Infection, dengue virus remission/reduction, IN VITRO",IC-50,1.10E-06,M